EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum microRNA 143 and 223 Gene Expression Profiles as Potential Biomarkers in Individuals with Hepatitis and COVID-19

Lucas Lima da Silva iD, Luciane Almeida Amado Leon iD, Otacílio da Cruz Moreira iD, Wagner Luis da Costa Nunes Pimentel Coelho, Vanessa Duarte da Costa, Claudia Alexandra Pontes Ivantes iD, Priscila Pollo-Flores iD, Lia Laura Lewis-Ximenez, Vanessa Salete de Paula iD, Livia Melo Villar iD

Viruses · 04.11.2024 · 16 (11) · 1734

DOI: 10.3390/v16111734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 04.11.2024. Verfasst von Lucas Lima da Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory for Viral Hepatitis, Institute Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil. Hauptthemen laut MEDLINE: COVID-19, MicroRNAs, Biomarkers, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: OSWALDO CRUZ FOUNDATION, FAPERJ, CAPES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) can act as biomarkers and descriptors of the association between infections and other diseases, such as hepatitis and COVID-19. This study aims to investigate the role of miRNA serum expression according to laboratory data concerning hepatitis and COVID-19. Seventy individuals recruited in Southern and Southeastern Brazil donated serum samples and were divided into four groups: (i) 20 negative subjects, (ii) 20 presenting hepatitis, (iii) 19 with COVID-19 and (iv) 11 with hepatitis and COVID-19. Three miRNAs (miR-122, miR-143 and miR-223) were evaluated using real-time PCR. Hematological and biochemical markers were also analyzed. MiR-143 and miR-223 were downregulated among the hepatitis/COVID-19 group (p < 0.05). A positive correlation was observed between miR-223 and lymphocytes. There was a negative correlation between alanine transaminase (ALT) and aspartate transaminase (AST) for miR-143 and miR-223 and gamma-glutamyl transferase (GGT), alkaline phosphatase (AP) and neutrophil/lymphocyte ratio (NLR) only for miR-223 (p < 0.05). For hepatic fibrosis (FIB-4), miR-122 and miR-143 had a greater association and miR-223 was more associated with a history of vaccination against COVID-19. MicroRNAs 143 and 223 could be useful as biomarkers for hepatitis coinfection with COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MicroRNAsBiomarkersSARS-CoV-2HumansMaleFemaleAdultMiddle AgedBrazilHepatitisAgedAspartate AminotransferasesGene Expression ProfilingAlanine Transaminase

Stichwörter der Autor:innen

COVID-19biomarkerhepatitismicroRNA

Substanzen

MicroRNAsBiomarkersAspartate AminotransferasesAlanine TransaminaseMIR223, humanMIRN143 microRNA, human

Autor:innen und Institutionen

  • National Reference Laboratory for Viral Hepatitis, Institute Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
  • Technological Development Laboratory, Institute Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
  • Molecular Virology and Parasitology Laboratory, Institute Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
  • Gastroenterology, Hepatology and Liver Transplantation Service, Nossa Senhora das Graças, Curitiba 80810-040, PR, Brazil.
  • Department of Clinical Medicine, Fluminense Federal University, Niterói 24220-000, RJ, Brazil.

ORCID-Profile: Lucas Lima da Silva, Luciane Almeida Amado Leon, Otacílio da Cruz Moreira, Claudia Alexandra Pontes Ivantes, Priscila Pollo-Flores, Vanessa Salete de Paula, Livia Melo Villar

Förderung

  • OSWALDO CRUZ FOUNDATION
  • FAPERJ
  • CAPES
  • National Council for Scientific and Technological Development
  • Oswaldo Cruz Foundation (FIOCRUZ) via INOVA FIOCRUZ VPPCB-005-FIO-20-2-52 program
  • Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
  • Higher Education Personnel Improvement Coordination (CAPES)

Zitieren

APA

da Silva, L. L., Leon, L. A. A., da Cruz Moreira, O., da Costa Nunes Pimentel Coelho, W. L., da Costa, V. D., Ivantes, C. A. P., Pollo-Flores, P., Lewis-Ximenez, L. L., de Paula, V. S., & Villar, L. M. (2024). Serum microRNA 143 and 223 Gene Expression Profiles as Potential Biomarkers in Individuals with Hepatitis and COVID-19. Viruses, 16(11), 1734. https://doi.org/10.3390/v16111734

Vancouver

da Silva LL, Leon LAA, da Cruz Moreira O, da Costa Nunes Pimentel Coelho WL, da Costa VD, Ivantes CAP, et al. Serum microRNA 143 and 223 Gene Expression Profiles as Potential Biomarkers in Individuals with Hepatitis and COVID-19. Viruses. 2024;16(11):1734. doi:10.3390/v16111734

BibTeX
@article{daSilva2024,
  author = {da Silva, Lucas Lima and Leon, Luciane Almeida Amado and da Cruz Moreira, Otacílio and da Costa Nunes Pimentel Coelho, Wagner Luis and da Costa, Vanessa Duarte and Ivantes, Claudia Alexandra Pontes and Pollo-Flores, Priscila and Lewis-Ximenez, Lia Laura and de Paula, Vanessa Salete and Villar, Livia Melo},
  title = {Serum microRNA 143 and 223 Gene Expression Profiles as Potential Biomarkers in Individuals with Hepatitis and COVID-19},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {1734},
  doi = {10.3390/v16111734}
}
Kostenlos starten →